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ABSTRACT 
Background: Diabetes and its complications are the major burden health problem worldwide, and diabetic neuropathy is one of 
the major complications. Vitamin D levels found to be signifi cantly lower in people with painful diabetic peripheral neuropathy 
compared with healthy people. The data about the vitamin D levels and severity of the neuropathy in Indonesia are very limited. 
Objective: This study aims to investigate the possible relationship between vitamin D levels and the severity of diabetic peripheral 
neuropathy. Methods: A cross-sectional study was carried out during the period from October 2019 to December 2019 on 53 
subjects with diabetic peripheral neuropathy. The patient’s clinical profi le including age, gender, and duration of diabetes, HbA1c, 
and associated microvascular complications was documented. The treatment history was recorded from electronic prescribing 
data. The severity of neuropathy was measured with the Toronto Clinical Neuropathy Scoring System. Serum 25-OH vitamin D 
levels were measured by enzyme immunoassays for the quantitative measurement of total serum 25-OH Vitamin D level in ng/mL. 
Results: Vitamin D levels based on the severity of neuropathy are divided into mild, moderate, and severe. At mild neuropathy 
severity, the average patient’s vitamin D level was 19±8.85ng/mL, at moderate severity the patient’s vitamin D level was 16.25±6.08 
ng/mL, and for severe neuropathy, the average vitamin D level was 13.35±6.20 ng/mL. Spearman correlation test obtained r value= 
-0.439 and p value=0.001. Conclusions: There is a moderate, signifi cant, and negative patterned correlation between vitamin D 
level and diabetic peripheral neuropathy severity.
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INTRODUCTION
Diabetes and its complications is the major burden 
health problem in worldwide and Indonesia (1,2). The 
data from national health survey in Indonesia showed that 
the prevalence of diabetes increase 2% among above 15 
years old population (2). Diabetic neuropathy is one of 
the major complications (2). The prevalence of diabetic 
peripheral neuropathy in newly diagnosed diabetic 
patients reaches about 8%. The proportion increase up to 
50% in patients with long-standing disease (3). Among 
15% of all diabetic patients will develop foot ulcer and 
nontraumatic amputation of lower limbs (4).
The pathogenesis of diabetic peripheral neuropathy 
is a multifactorial process and multiple hypotheses have 
been postulated. Previous basic research showed that 
abnormal expression of sodium and calcium channels, 
metabolic and autoimmune disorders which lead to glial 
cell activation contribute to the pathogenesis (5). Recent 
studies showed that blood vessel changes and  activation 
of central pain mechanisms also played signifi cant role 
(5,6). 
Low vitamin D levels are associated with obesity 
and insulin resistance (7). Low 25-hydroxyvitamin D 
levels have been associated with sensory neuropathy in 
10 
Jurnal Gizi Klinik Indonesia, Vol. 17, No. 1, Juli 2020: 9-14
Diabetic Neuropathy Examination tools (12). The type 2 
diabetes mellitus patients were obtained from outpatient 
neurology clinic of Bethesda Hospital Yogyakarta Indonesia. 
A standardized instrument was used to record demographic 
details of the patients. The patient’s clinical profi le including 
age, gender, and duration of diabetes, status of glycemic 
control refl ected by HbA1c and associated microvascular 
complications were documented. The treatment history was 
recorded from electronic prescribing data. 
The severity of painful diabetic neuropathy. The 
severity of neuropathy was measured with the Toronto 
Clinical Neuropathy Scoring System (TCNS) (13). The 
individual patient’s TCNS score was documented out of a 
total of 19. Severity of neuropathy was classifi ed based on 
the score as: no neuropathy (0 to 5), mild neuropathy (6 to 8), 
moderate (9 to 11), and severe diabetic neuropathy (12 to 19). 
Vitamin D serum level. The vitamin D level was 
measured by standardized method in Prodia Research 
Laboratory. Serum 25-OH vitamin D levels were 
measured by enzyme immunoassays for the quantitative 
measurement of total serum 25-OH Vitamin D level in 
ng/mL. The level < 10 ng/mL is defi ciency, 10-30 ng/mL 
is in-suffi ciency, and 30-100 ng/mL is suffi ciency (14).
Data analysis 
Continuous variables were assessed for normality 
using Shapiro–Wilk’s test. If the variables were normally 
distributed they were expressed as mean ± standard 
deviation, otherwise median (interquartile range). 
Categorical variables were expressed either as percentage 
or proportions. A comparison of normally distributed 
continuous variables was done by independent sample 
t-test, non–normally distributed continuous variables by 
Mann-Whitney U test, and categorical variables by either 
Chi-Square test or Fisher’s-exact test based on the number 
of observations. Data analysis and validation was carried 
out by SPSS. All p-values less than 0.05 were considered 
statistically signifi cant. 
RESULTS
The study was conducted on 53 T2DM peripheral 
neuropathy patients, consisting of 11 male patients 
(20.8%) and 42 female patients (79.2%). The mean age of 
diabetes (8). Vitamin D levels also might be correlated 
with the severity of the neuropathy (9). 
The role of vitamin D in diabetic neuropathy has 
been studied in previous studies. A recent systematic 
review showed  that vitamin D defi ciency is associated 
with the generation and development of DPN in Caucasian 
with type 2 diabetes mellitus (T2DM), and in Asian, 
diabetic patients with vitamin D defi ciency are 1.22 times 
to suffer from DPN compared with normal vitamin D 
level (10). A study showed that 25-hydroxyvitamin D 
levels were signifi cantly lower in people with painful 
diabetic peripheral neuropathy compared with healthy 
volunteers and no diabetic peripheral neuropathy  patients. 
Lower 25-hydroxyvitamin D level also correlated with 
lower cold detection thresholds (r=0.39, p=0.02) and 
subepidermal nerve fi bre densities (r=0.42, p=0.01) (11). 
The data about the vitamin D levels and severity of the 
neuropathy in Indonesia are very limited. This study aims 
to investigate the possible relationship between vitamin D 
levels and the severity of diabetic peripheral neuropathy.
METHODS
Study design and participants
A cross sectional study was carried out during 
the period from October 2019 to December 2019 on 53 
subject with diabetic peripheral neuropathy. The study 
included all patients above the age of 18 years with T2DM 
with symptoms suggestive of peripheral neuropathy. 
Patients with neuropathy due to causes other than diabetes 
and those who refused informed consent were excluded 
from the study. The sample size was calculated based on 
estimate of 20% prevalence of neuropathy in diabetes, 
allowing for an error of 10%, and thereby a total of 50 
patients were recruited. After obtaining approval from 
the institutional ethical committee (498/E/RSB/2019), 
patients were recruited in the study based on the inclusion 
criteria. Informed consent was obtained and the patients 
were subjected to history and physical examination.
Measures
In this study, the diagnosis of diabetic peripheral 
neuropathy based on systematic measurement by a 
neurologist with Diabetic Neuropathy Symptom and 
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observed patients was 57.8±8.8 years. Of the 53 patients 
who participated in the study, 29 patients had T2DM for 
more than 15 years (54.7%), 12 patients had T2DM for 10 
to 15 years (22.6%), and 12 patients had T2DM for less 
than 10 years (22.6%) (Table 1). In this study, vitamin 
D levels were measured in all study patients. The mean 
vitamin D level in male patients was 20.64±3.96 ng/mL 
and in female patients was 14.24±7.04 ng/mL (Table 
2). The results of measurement of vitamin D level based 
on the severity of neuropathy are divided into mild, 
moderate, and severe. At mild neuropathy severity, the 
average of patient’s vitamin D level was 19±8.85 ng/mL, 
at the moderate severity the patient’s vitamin D level 
was 16.25±6.08 ng/mL, and for severe neuropathy, the 
average vitamin D level was 13.35±6.20 ng/mL (Table 
3). Correlation analysis in Table 3 shows the correlation 
between vitamin D level and neuropathy severity and the 
result shows that decreasing vitamin D level correlates 
with increased neuropathy severity (r = -0.439; p=0.001).
There was a statistically signifi cant relationship 
between gender, hypertension, and status of glycemic 
control as factors that affect patients’ vitamin D levels 
(p<0.05). Confounding variables such as duration of 
DM, history of cardiovascular disease, oral antidiabetic 
medication, and insulin therapy did not show a signifi cant 
relationship with the patient’s vitamin D level (p>0.05).
DISCUSSION
The data showed that only one study subject had 
suffi cient vitamin D levels. The proportion of subjects 
with a defi ciency was 12/53 (22.6%). Most of the study 
subjects had insuffi cient vitamin D levels (75.4%). This 
result is consistent with some previous studies. The study 
from Bayani, from 120 T2DM patients showed that 
vitamin D level was defi cient in 77 (64.2%), insuffi cient 
in 30 (25%), and suffi cient in 13 (10.3%) patients (15). 
A large epidemiological study showed that the overall 
prevalence of patients with low vitamin D levels (vitamin 
D defi ciency and insuffi ciency) was 1257 (83.7%); and 
1231 (82%) were newly diagnosed cases. Out of 1257 
(83.7%) patients with low vitamin D levels, 60.9% of 
patients had vitamin D defi ciency, and 22.9% of patients 
had vitamin D insuffi ciency (16). 
Table 1. Baseline characteristic
Characterisctic n=53 %
Gender
   Male












Duration of DM (years)
   <10
   10-15








   Yes






   Yes





Vitamin D level (ng/mL)
   Defi ciency (10)
   Insuffi ciency (10-30)
   Sufi ciency (30-100)










   Yes






   Yes 





Status of glycemic control
   Controlled





This study showed that patients with severe 
neuropathy are correlated with low vitamin D status. 
Some previous studies showed a similar result. The study 
from 60 patients with diabetes (thirty with neuropathy and 
thirty without neuropathy) showed that vitamin D levels 
were signifi cantly decreased in diabetic patients and 
those with neuropathy when compared to those without 
neuropathy (p<0.05). Vitamin D levels were signifi cantly 
reduced with increasing severity of neuropathy (p=0.001) 
(17). Another study conducted by Ahmadieh reported that 
the prevalence of diabetic neuropathy increases with a 
decrease in 25-OH vitamin D level. The percentage of 
neuropathy increased in patients with 25-OH vitamin D 
level below 20 ng/mL (18). 
There is emerging evidence that vitamin D 
is a neurotrophic substance, but its role in diabetic 
neuropathic pain needs further studies (19). Some 
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weekly 50000 IU of vitamin D3 for 12 weeks orally. 
Among 60 T2DM patients, 58 completed the study. 
At the end of study, HbA1c, vitamin D, and patient’s 
clinical condition assessed by Michigan Neuropathy 
Screening Instrument (MNSI) (both questionnaire 
and physical examination) improved significantly 
(p-value<0.001). Oral supplementation of vitamin D 
(50000 IU) once a week for 12 weeks was associated 
with a signifi cant decrease in the symptoms and signs 
of diabetic neuropathy (21). Lee and Chen showed that 
vitamin D supplementation over 3 months improved 
neuropathic symptoms by 50% in diabetic patients with 
vitamin D defi ciency at baseline (22).  
The mean vitamin D level in male patients in 
this study was 20.64±3.96 ng/mL, and female patients 
were 14.24±7.04 ng/mL. Gender was found to have a 
statistically signifi cant effect on vitamin D levels. In 
previous studies, it was stated that gender affected vitamin 
D status, in which 25(OH)D level of women were lower 
than men and played a role in determining the severity 
of coronary artery disease (23). The duration of T2DM 
patients in this study were divided into less than 10 
years, 10-15 years and more than 15 years. The duration 
of DM was found to be statistically insignifi cant due to 
vitamin D level. Based on theory that the severity of DM 
associated with prolonged hyperglycemia that can cause 
nerve damage and exacerbate neuropathy symptoms (24).
Hypertension in this study was signifi cantly related 
to vitamin D level. Another study also found that every 
10% increase in plasma 25(OH)D level was associated 
with a decrease in diastolic and systolic blood pressure 
and 8.1% decreased hypertension (OR=0.92, 95% CI: 
0.87–0.97; p=0.002) (25). In this study, the history of 
cardiovascular disease did not signifi cantly infl uence 
vitamin D level. Maintaining optimal vitamin D level is 
important not only for maintaining calcium homeostasis 
but also for the risk of cardiovascular disease and 
blood pressure control. Vitamin D has an effect on the 
cardiovascular system by reducing the activity of the 
renin angiotensin-aldosterone system, decreases blood 
pressure, and has anti-infl ammatory and antithrombotic 
effect (26).
Oral antidiabetic medication and insulin therapy 
do not signifi cantly infl uence vitamin D level. The status 
Table 2. The vitamin D level comparison based on the 










   Male






Duration of DM 
(years)
   <10
   10-15









   Yes








   Yes








   Yes







   Yes 






Status of glycemic 
control
   Controlled






Table 3. The vitamin D level based on the severity of 
neuropathy
Vitamin D Severity of neuropathyMild Moderate Severe
Mean (ng/mL) 19.00 16.26 13.35
Standard deviation (ng/mL) 8.85 6.08 6.20
Signifi cance 0.001
researcher  hypothesized that vitamin D deficiency 
may potentiate diabetic nerve damage and may impair 
nociceptor function, resulting in pain at a threshold of 
serum 25(OH) vitamin D higher than that in the non-
diabetic population (20). 
The next important question is “should we 
add vitamin D treatment in patients with painful 
diabetic neuropathy”. A quasi-experimental trial sixty 
type 2 DM subjects (30-65 years old) with painful 
diabetic neuropathy was performed. Patients received 
13 
Rizaldy Taslim Pinzon, et al.: The correlation between vitamin D defi ciency and the severity of painful diabetic neuropathy in patients 
of glycemic control refl ected by HbA1c is signifi cantly 
related to vitamin D level. The same thing also found in 
another study that there is a signifi cant relationship in the 
vitamin D supplementation to decrease HbA1c (7.9±1.7% 
vs 7.4±1.2%, p=0.001) (27).
The study has some limitations. It was a hospital-
based study and hence the results may not be generalized 
to the population on a community basis. The authors 
could not fi nd enough subjects with normal vitamin D 
status. We also did not compare the vitamin D level in 
patients without neuropathy. As a preliminary study on 
the correlation of vitamin D with neuropathy in Indonesia, 
further studies and clinical trials are warranted.
CONCLUSIONS
There is a moderate, significant, and negative 
patterned correlation between vitamin D level and 
diabetic peripheral neuropathy severity.
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